BEVC

BEVC is a venture capital firm investing in early-stage biotechnology companies, focusing on innovative therapeutics. They are scientists turned entrepreneurs and investors, driven by the ambition to advance science in service of a better world. They bring capital, domain expertise, and deep networks to help founders turn bold ideas into thriving companies. They invest at the frontiers of biology and health, AI and the future of intelligence, and deep tech – from molecules to materials to energy. They invest early with conviction, apply technical and market rigor, and work hands-on with teams to build scalable, defensible businesses. They are the preferred investor for the thriving UCSF and Berkeley ecosystems and Bakar funded initiatives. Their partners include Montara Therapeutics, PinkDx, and others. They have invested in companies such as Montara Therapeutics, which is developing novel treatments using the BrainOnly™ Platform with a grant from The Michael J. Fox Foundation, and PinkDx, which announced a second close of its upsized Series A financing with new investors including BEVC. They are based in Berkeley, California, and are embedded in a world-class innovation ecosystem and leading Bay Area research institutions. Their backgrounds span startups, academia, corporates, and capital markets, giving them the edge to help teams navigate complexity and execute with confidence. They are called BEVC to reflect the founders they back: Bold, Exceptional, Visionary, and Credible.